These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 7872843)
1. Why neuroleptic withdrawal in schizophrenia? Carpenter WT; Tamminga CA Arch Gen Psychiatry; 1995 Mar; 52(3):192-3. PubMed ID: 7872843 [No Abstract] [Full Text] [Related]
2. Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Gilbert PL; Harris MJ; McAdams LA; Jeste DV Arch Gen Psychiatry; 1995 Mar; 52(3):173-88. PubMed ID: 7872841 [No Abstract] [Full Text] [Related]
3. Neuroleptic withdrawal in schizophrenic patients. Baldessarini RJ; Viguera AC Arch Gen Psychiatry; 1995 Mar; 52(3):189-92. PubMed ID: 7872842 [No Abstract] [Full Text] [Related]
4. Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come. Meltzer HY Arch Gen Psychiatry; 1995 Mar; 52(3):200-2. PubMed ID: 7872845 [No Abstract] [Full Text] [Related]
6. Long-term treatment for lifetime disorders? Greden JF; Tandon R Arch Gen Psychiatry; 1995 Mar; 52(3):197-200. PubMed ID: 7872844 [No Abstract] [Full Text] [Related]
7. Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach. Jeste DV; Gilbert PL; McAdams LA; Harris MJ Arch Gen Psychiatry; 1995 Mar; 52(3):209-12. PubMed ID: 7872848 [No Abstract] [Full Text] [Related]
8. The early course of schizophrenia and long-term maintenance neuroleptic therapy. Nuechterlein KH; Gitlin MJ; Subotnik KL Arch Gen Psychiatry; 1995 Mar; 52(3):203-5. PubMed ID: 7872846 [No Abstract] [Full Text] [Related]
9. The treatment of tardive dyskinesia. Raja M Schweiz Arch Neurol Psychiatr (1985); 1996; 147(1):13-8. PubMed ID: 8685689 [TBL] [Abstract][Full Text] [Related]
10. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol. Bobba R Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119 [No Abstract] [Full Text] [Related]
15. Neuroleptic discontinuation and tardive dyskinesia risk. Sherr JD; Medoff D; Thaker G Am J Psychiatry; 1999 Jul; 156(7):1125-6. PubMed ID: 10401483 [No Abstract] [Full Text] [Related]
16. Prevention and management of tardive dyskinesia. Jeste DV; Wyatt RJ J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473 [TBL] [Abstract][Full Text] [Related]
17. Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment. Perényi A; Frecska E; Bagdy G; Révai K Acta Psychiatr Scand; 1985 Nov; 72(5):430-5. PubMed ID: 2868608 [TBL] [Abstract][Full Text] [Related]
18. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs. Kristjansen P Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796 [No Abstract] [Full Text] [Related]
19. Tardive dyskinesia--reversible and persistent. Jeste DV; Potkin SG; Sinha S; Feder S; Wyatt RJ Arch Gen Psychiatry; 1979 May; 36(5):585-90. PubMed ID: 35116 [TBL] [Abstract][Full Text] [Related]
20. Neuroleptic-induced emesis: a new indication for clozapine? Bustillo JR; Buchanan RW Biol Psychiatry; 1995 Aug; 38(3):194-5. PubMed ID: 7578665 [No Abstract] [Full Text] [Related] [Next] [New Search]